Free Trial
NASDAQ:RPID

Rapid Micro Biosystems Q3 2026 Earnings Date & Estimates

Rapid Micro Biosystems logo
$0.89 0.00 (0.00%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$0.91 +0.02 (+1.96%)
As of 10/9/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Rapid Micro Biosystems is scheduled to report Q3 2026 earnings on Friday, November 6, 2026, before market opens. The conference call is scheduled for 8:30 AM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens
Conference Call
8:30 AM ET

What Analysts Expect from Rapid Micro Biosystems in Q3 2026

Rapid Micro Biosystems is expected to post earnings of -$0.20 per share on revenue of $9.88 million. In the same quarter a year earlier Rapid Micro Biosystems reported -$0.26 per share on revenue of $7.84 million. Rapid Micro Biosystems last reported on August 7, 2026, posting -$0.27 per share and missing the -$0.2433 consensus estimate. Rapid Micro Biosystems has beaten the consensus EPS estimate in 1 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.20
Expected Revenue
$9.88 million
Prior-Year EPS
-$0.26
Prior-Year Revenue
$7.84 million
Expected Revenue Growth
+26.1%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.27 (Missed by -$0.0267)
Last Quarter Revenue
$8.05 million
EPS Beat Rate
1 of last 8 quarters

Rapid Micro Biosystems Q3 2026 Earnings FAQ

Rapid Micro Biosystems (NASDAQ:RPID) is scheduled to report Q3 2026 earnings on Friday, November 6, 2026, before market opens.

Rapid Micro Biosystems' Q3 2026 earnings conference call is scheduled for Friday, November 6, 2026 at 8:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Rapid Micro Biosystems to post earnings of -$0.20 per share for Q3 2026.

The consensus revenue estimate for Rapid Micro Biosystems is $9.88 million for Q3 2026.

Rapid Micro Biosystems Earnings Headlines

Rapid Micro Biosystems (NASDAQ:RPID) Upgraded at Roth Capital
Trump To Relaunch USD?
President Trump's summit with Xi Jinping drew headlines for tariffs and trade truces, but the real story may be a bid to reset the US dollar. Porter Stansberry says the meeting, attended by figures like Elon Musk, Jensen Huang and Larry Fink, connects to a 13-nation pact designed to cut China out of a massive investment wave.tc pixel
See More Rapid Micro Biosystems Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Rapid Micro Biosystems? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rapid Micro Biosystems and other key companies, straight to your email.

About Rapid Micro Biosystems

Rapid Micro Biosystems (NASDAQ:RPID) develops automated solutions for microbial quality control in pharmaceutical, biotechnology, and other regulated manufacturing environments. Its technologies are designed to help manufacturers detect, enumerate, and monitor microorganisms while reducing manual laboratory work and supporting faster release of products and production areas.

The company’s primary platform is the Growth Direct System, an automated microbial detection and enumeration system used for applications such as environmental monitoring and bioburden testing. Rapid Micro Biosystems also provides related consumables, software, data-management capabilities, and service and support offerings intended to integrate microbial testing into customers’ quality-control workflows.

Founded in 2006 and headquartered in Lowell, Massachusetts, Rapid Micro Biosystems serves customers in the biopharmaceutical and related life sciences industries. The company’s solutions are marketed internationally, supporting manufacturing operations across North America, Europe, and other global regions. Rapid Micro Biosystems became a publicly traded company on the Nasdaq exchange in 2021 under the symbol RPID.

View Rapid Micro Biosystems Profile